Benzinga's Top Upgrades, Downgrades For November 3, 2020

Upgrades

• For Matson Inc MATX, Stephens & Co. upgraded the previous rating of Equal-Weight to the current rating Overweight. In the third quarter, Matson showed an EPS of $1.63, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of 53.71 and a 52-week-low of 23.75. At the end of the last trading period, Matson closed at $52.22.
• For Inspire Medical Systems Inc INSP, Oppenheimer upgraded the previous rating of Underperform to the current rating Perform. In the third quarter, Inspire Medical Systems showed an EPS of $0.39, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of 135.2 and a 52-week-low of 40.53. At the end of the last trading period, Inspire Medical Systems closed at $121.49.
• For IPG Photonics Corp IPGP, Northcoast Research upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, IPG Photonics showed an EPS of $1.29, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of 202.58 and a 52-week-low of 98.04. IPG Photonics closed at $190.65 at the end of the last trading period.
• According to B of A Securities, the prior rating for CNA Financial Corp CNA was changed from Underperform to Neutral. CNA Financial earned $0.71 in the third quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of 51.3 and a 52-week-low of 25.18. At the end of the last trading period, CNA Financial closed at $31.61.
• For Arista Networks Inc ANET, B of A Securities upgraded the previous rating of Neutral to the current rating Buy. Arista Networks earned $2.42 in the third quarter, compared to $2.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of 267.3 and a 52-week-low of 156.63. Arista Networks closed at $216.13 at the end of the last trading period.
• According to Goldman Sachs, the prior rating for Pinduoduo Inc PDD was changed from Neutral to Buy. In the second quarter, Pinduoduo showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of 98.96 and a 52-week-low of 30.2. Pinduoduo closed at $91.62 at the end of the last trading period.
• According to Morgan Stanley, the prior rating for Constellation Brands Inc STZ was changed from Equal-Weight to Overweight. Constellation Brands earned $2.76 in the second quarter, compared to $2.72 in the year-ago quarter. The current stock performance of Constellation Brands shows a 52-week-high of 208.55 and a 52-week-low of 104.28. Moreover, at the end of the last trading period, the closing price was at $176.36.
• Morgan Stanley upgraded the previous rating for Monster Beverage Corp MNST from Equal-Weight to Overweight. In the second quarter, Monster Beverage showed an EPS of $0.59, compared to $0.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of 87.05 and a 52-week-low of 50.06. Monster Beverage closed at $77.92 at the end of the last trading period.
• JP Morgan upgraded the previous rating for Paycom Software Inc PAYC from Underweight to Neutral. For the second quarter, Paycom Software had an EPS of $0.62, compared to year-ago quarter EPS of $0.75. The current stock performance of Paycom Software shows a 52-week-high of 397.51 and a 52-week-low of 163.42. Moreover, at the end of the last trading period, the closing price was at $360.91.
• For BP PLC BP, Morgan Stanley upgraded the previous rating of Underweight to the current rating Equal-Weight. In the third quarter, BP showed an EPS of $0.03, compared to $0.66 from the year-ago quarter. The current stock performance of BP shows a 52-week-high of 40.08 and a 52-week-low of 14.74. Moreover, at the end of the last trading period, the closing price was at $16.10.

Downgrades

• According to Oppenheimer, the prior rating for SolarEdge Technologies Inc SEDG was changed from Outperform to Perform. In the third quarter, SolarEdge Technologies showed an EPS of $1.21, compared to $1.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of 317.88 and a 52-week-low of 67.02. SolarEdge Technologies closed at $267.72 at the end of the last trading period.
• Susquehanna downgraded the previous rating for Skechers USA Inc SKX from Positive to Neutral. For the third quarter, Skechers USA had an EPS of $0.53, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 44.5 and a 52-week-low of 17.06. Skechers USA closed at $30.50 at the end of the last trading period.
• For The Mosaic Co MOS, ScotiaBank downgraded the previous rating of Sector Outperform to the current rating Sector Perform. For the third quarter, Mosaic had an EPS of $0.23, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of 22.5 and a 52-week-low of 6.5. Mosaic closed at $19.56 at the end of the last trading period.
• For Endurance International Group Holdings Inc EIGI, Credit Suisse downgraded the previous rating of Outperform to the current rating Neutral. For the third quarter, Endurance Intl Gr Hldgs had an EPS of $0.05, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 9.48 and a 52-week-low of 1.31. Endurance Intl Gr Hldgs closed at $9.41 at the end of the last trading period.
• According to Raymond James, the prior rating for IPG Photonics Corp IPGP was changed from Outperform to Market Perform. IPG Photonics earned $1.29 in the third quarter, compared to $1.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of 202.58 and a 52-week-low of 98.04. IPG Photonics closed at $190.65 at the end of the last trading period.
• Piper Sandler downgraded the previous rating for Pacific Biosciences of California Inc PACB from Overweight to Neutral. In the third quarter, Pacific Biosciences showed an EPS of $0.14, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of 15.12 and a 52-week-low of 2.2. At the end of the last trading period, Pacific Biosciences closed at $13.25.
• According to Keefe, Bruyette & Woods, the prior rating for Greenhill & Co Inc GHL was changed from Market Perform to Underperform. In the third quarter, Greenhill & Co showed an EPS of $0.49, compared to $0.63 from the year-ago quarter. At the moment, the stock has a 52-week-high of 23.08 and a 52-week-low of 7.28. Greenhill & Co closed at $13.05 at the end of the last trading period.
• Raymond James downgraded the previous rating for Jounce Therapeutics Inc JNCE from Strong Buy to Market Perform. For the second quarter, Jounce Therapeutics had an EPS of $0.82, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of 11.7201 and a 52-week-low of 2.85. Jounce Therapeutics closed at $6.82 at the end of the last trading period.

Initiations

• With a current rating of Outperform, RBC Capital initiated coverage on Spruce Biosciences Inc SPRB. The price target seems to have been set at $28.00 for Spruce Biosciences. The current stock performance of Spruce Biosciences shows a 52-week-high of 22.515 and a 52-week-low of 15.38. Moreover, at the end of the last trading period, the closing price was at $20.30.
• With a current rating of Buy, Citigroup initiated coverage on Shattuck Labs Inc STTK. The price target seems to have been set at $36.00 for Shattuck Labs. The current stock performance of Shattuck Labs shows a 52-week-high of 27.245 and a 52-week-low of 19.5001. Moreover, at the end of the last trading period, the closing price was at $26.87.
• B of A Securities initiated coverage on NICE Ltd NICE with a Buy rating. The price target for NICE is set to $280.00. In the second quarter, NICE showed an EPS of $1.37, compared to $1.25 from the year-ago quarter. The stock has a 52-week-high of 240.58 and a 52-week-low of 110.59. At the end of the last trading period, NICE closed at $229.60.
• For Kronos Bio Inc KRON, Cowen & Co. initiated coverage, by setting the current rating at Outperform. The current stock performance of Kronos Bio shows a 52-week-high of 33.65 and a 52-week-low of 25.57. Moreover, at the end of the last trading period, the closing price was at $26.93.
• With a current rating of Buy, Truist Securities initiated coverage on HOOKIPA Pharma Inc HOOK. The price target seems to have been set at $21.00 for HOOKIPA Pharma. HOOKIPA Pharma earned $0.28 in the second quarter, compared to $0.63 in the year-ago quarter. The current stock performance of HOOKIPA Pharma shows a 52-week-high of 14.3662 and a 52-week-low of 5.8. Moreover, at the end of the last trading period, the closing price was at $9.82.
• With a current rating of Underperform, Baird initiated coverage on Editas Medicine Inc EDIT. The price target seems to have been set at $14.00 for Editas Medicine. For the second quarter, Editas Medicine had an EPS of $0.43, compared to year-ago quarter EPS of $0.69. The stock has a 52-week-high of 39.96 and a 52-week-low of 14.01. At the end of the last trading period, Editas Medicine closed at $31.30.
• SVB Leerink initiated coverage on Spruce Biosciences Inc SPRB with an Outperform rating. The price target for Spruce Biosciences is set to $35.00. The current stock performance of Spruce Biosciences shows a 52-week-high of 22.515 and a 52-week-low of 15.38. Moreover, at the end of the last trading period, the closing price was at $20.30.
• With a current rating of Buy, Fearnleys initiated coverage on Cheniere Energy Inc LNG. The price target seems to have been set at $61.00 for Cheniere Energy. For the second quarter, Cheniere Energy had an EPS of $0.78, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of 67.11 and a 52-week-low of 27.06. At the end of the last trading period, Cheniere Energy closed at $47.06.
• Goldman Sachs initiated coverage on Kronos Bio Inc KRON with a Buy rating. The price target for Kronos Bio is set to $45.00. The stock has a 52-week-high of 33.65 and a 52-week-low of 25.57. At the end of the last trading period, Kronos Bio closed at $26.93.
• With a current rating of Buy, Goldman Sachs initiated coverage on Chindata Group Holdings Ltd CD. The price target seems to have been set at $17.60 for Chindata Group Holdings. The stock has a 52-week-high of 16.76 and a 52-week-low of 13.12. At the end of the last trading period, Chindata Group Holdings closed at $13.84.
• With a current rating of Overweight, Piper Sandler initiated coverage on Kronos Bio Inc KRON. The price target seems to have been set at $50.00 for Kronos Bio. The current stock performance of Kronos Bio shows a 52-week-high of 33.65 and a 52-week-low of 25.57. Moreover, at the end of the last trading period, the closing price was at $26.93.
• With a current rating of Outperform, Credit Suisse initiated coverage on Spruce Biosciences Inc SPRB. The price target seems to have been set at $28.00 for Spruce Biosciences. At the moment, the stock has a 52-week-high of 22.515 and a 52-week-low of 15.38. Spruce Biosciences closed at $20.30 at the end of the last trading period.